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ABSTRACT
Objective: The objective of this study was to assess the in vitro xanthine oxidase (XO) inhibiting activity of the methanolic leaf extract of the 
Rhusmysorensis.
Methods: Uric acid is synthesized in the presence of XO which is an essential enzyme. Various concentrations of the leaf extract were taken. XO 
inhibiting activity was spectrophotometrically assayed. By increasing absorbance at 295 nm, the degree of enzyme spontaneity was determined.
Results: Inhibition concentration 50 (IC50) of the methanolic extract of R. mysorensis leaves was 45.24±0.34 µg/ml, compared with IC50 value of the 
standard allopurinol of 7.8±1.28 µg/ml.
Conclusion: Methanol extract of R. mysorensis can be used to treat hyperuricemia and gout after proper preclinical and clinical studies.
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INTRODUCTION
Gout is a known metabolic disorder distressing humans and its 
morbidity is present keeping on growing over the past years. The gout 
prevalence is diagnosed by increased level of uric acid that accumulates 
in joints and kidneys, causing gouty arthritis and nephrolithiasis [1,2]. 
An enzyme xanthine oxidase (XO) which catalyzes the hydroxylation 
of hypoxanthine which converts xanthine into uric acid. Then, the uric 
acid is excreted by kidneys. Production of excessive otherwise uric acid 
elimination is decreased which results into hyperuricemia [3]. The 
drugs used for this purpose are uricosurics and uricostatics. Uricosuric 
drugs work by inhibiting the absorption of uric acid in the kidney 
tubules, whereas uricostatic drug inhibits XO enzyme which converts 
hypoxanthine into xanthine and it is converted into uric acid, thereby 
decreases the production of uric acid. The World Health Organization 
reveals that medicinal plants would be the best source of drugs. Before 
using it in humans every plants should be investigated for its safety and 
efficacy.
R. mysorensis belonging to the family of Anacardiaceae is a shrub 
with thorny branches found in hot dry places and stony regions in 
India. Reports suggest that the plant contains alkaloids, glycosides, 
flavonoids, saponins, tannins, sterols, phenols, amino acids, and protein. 
Earlier studies of the plant claim that it has potential hepatoprotective, 
antimicrobial, antiurolithiatic, antidiabetic, hypolipidemic, and 
antioxidant activities. Folk usage of the plant suggested that its use in 
diabetes, antifertility, psoriasis, and diarrhea problems [4]. However 
there is no relavant study about inhibiting activity of xanthine oxidase 
of R. mysorensis. Hence, the inhibitory activity for XO in this study was 
analyzed using methanolic extract of the leaves of R. mysorensis.
MATERIALS AND METHODS
Plant material collection
The whole plant R. mysorensis was collected from hilly Tirupati region, 
Andhra Pradesh. Authentication for the plant is done by Dr. Madhav 
Chetty. K, Department of Botany, Sri Venkateswara University, Tirupati.
Extraction of plant material
Leaves were removed and air dried under shade, powdered and it was 
stored in an airtight container. Weigh 500 g of the powdered material 
was extracted with methanol (80%) by the process of soxhlation. The 
filtrate was concentrated at reduced pressure by rotary flash vacuum 
evaporator [5].
Drugs and chemicals
XO, xanthine, and allopurinol were obtained from HiMedia Labs, 
Mumbai, India. The drugs and chemicals used for this study were 
acquired with commercial and diagnostic category.
XO Inhibiting (XOI) activity [6]
Inhibiting activity of XO was spectrophotometrically assayed in aerobic 
environments by means of substrate - xanthine. The standard drug 
allopurinol (1 mg/ml) and the extract were prepared by dissolving in 
dimethyl sulfoxide initially (not >5% of total volume) and then made up 
to the required volume using potassium dihydrogen phosphate buffer 
with pH of 7.5. Then, assay mixture consisting 1 ml of extract at different 
concentrations (5–100 µg/ml), 2.9 ml potassium dihydrogen phosphate 
buffer with pH of 7.5, and 0.1 ml XO enzyme solution (0.1 U/ml in 
potassium dihydrogen phosphate buffer at pH of 7.5 is prepared 
instantly previous to work). After preincubation for 15 min at about 
25°C, 2 ml of substrate solution was added to initiate the reaction. The 
assay mixture was incubated at 25°C for 30 min, by the addition of 1 N 
HCl, the reaction was then stopped. At 290 nm, absorbance is measured 
against blank. Allopurinol (5–100 μg/ml), recognized inhibitor of XO, is 
selected as a positive control. XO 1 unit is the quantity needed to yield 
1 mmol of uric acid per minute by 25°C[6,7]. XO inhibiting activity was 
calculated as percentage inhibition as given below.
Percentage inhibition={(A-B)–(C-D)/(A-B)}×100
Here, A - is the enzyme activity without fraction,
B - is the control for A without fraction and enzyme,
C and D were the fraction activity with or without XO.
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In triplicates, the assay is made and the values for inhibition 
concentration 50 (IC50) were calculated based on the inhibitory 
activity.
RESULTS AND DISCUSSION
The present study is conducted to examine XO inhibiting activity 
for R. mysorensis leaf extract that might have the perspective to treat 
increased amount of uric acid and gout. The synthesis of uric acid by the 
conversion of hypoxanthine into xanthine, the oxidative pathway which 
occurs in the presence of enzymes XO and guanase, continued with uric 
acid oxidized from xanthine which is catalyzed by XO. Inhibiting the XO 
is thus very essential and necessary as pharmacological interference for 
gout and hyperuricemia [7].
Various concentrations of the leaf extract were taken and XOI activity 
was assayed by spectrophotometrically. The enzyme inhibitory activity 
was calculated by raising the absorbance to about 295 nm. The IC50 of 
the methanolic extract of R. mysorensis leaves was 45.24±0.34 µg/ml, 
compared with IC50 value of the standard allopurinol of 7.8±1.28 µg/ml. 
The results are given in Table 1.
CONCLUSION
We concluded that the methanolic extract of R. Mysorensis leaves 
processes and having a good XO inhibiting activity, thereby it has the 
bioactive elements helpful for the management of diseases occurred by 
XO. Hence, further in future, it is necessary to make studies on isolation 
of biologically active substances those effects with XO inhibiting 
activity.
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Table 1: In vitro XO inhibitory activity of R. mysorensis leaves
Drugs Percentage XO inhibition IC50 (µg/ml)
5 µg/ml 10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml
R. mysorensis leaves extract 27.54±0.96 33.71±0.29 41.25±0.53 51.44±0.89 63.52±0.64 45.24±0.34
Allopurinol (Std.) 31.87±0.32 63.38±0.55 78.63±0.84 86.61±0.55 93.02±1.28 7.8±1.28
Values are mean±SEM of three parallel measurements, R. mysorensis: Rhus mysorensis, XO: Xanthine oxidase
